On Aug. 30, 2024, Novavax announced the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705) had received Emergency Use…
On Aug. 18, 2023, the Maryland Department of Health has confirmed and reported a positive case of locally…
On Jul. 11, 2022, the National Institute of Allergy and Infectious Diseases (NIAID) launched an early-stage clinical trial…
On Jun. 28, 2022, the National Institutes of Health (NIH) announced that a Phase 1 clinical trial of…
On May 6, 2022, the National Institute of Allergy and Infectious Diseases (NIAID) announced that it had launched…
On Mar. 5, 2022, the U.S. Department of Agriculture’s Animal and Plant Health Inspection Service confirmed the presence…
On Jan. 10, 2022, in a first-of-its-kind surgery, a 57-year-old patient with terminal heart disease received a successful…
On Dec. 28, 2021, researchers at the Walter Reed Army Institute of Research in Silver Spring, Maryland announced…
On Nov. 17, 2021, scientists at the Centers for Disease Control and Prevention (CDC) announced they were collaborating…
On Nov. 15, 2021, a large, long-term study of the impacts of COVID-19 on children announced it had…
On Jun. 1, 2021, a first-in-human, Phase 1 trial assessing the safety and immunogenicity of an investigational nanoparticle…
On Apr. 23, 2021, the NIH announced that a study assessing how people with immune system deficiencies or…
On Apr. 13, 2021, Rigel Pharma announced the completion of patient enrollment in a multi-center Phase 2 clinical…
On Mar. 11, 2021, Rigel Pharma announced the completion of patient enrollment in a multi-center Phase 2 clinical…
On Oct. 30, 2020, Novavax announced the expansion of its Maryland campus to accommodate the companyï¾’s rapid growth…
On Aug. 24, 2020, Catalent announced that it had contracted to provide drug substance manufacturing to AstraZeneca for…
On Aug. 14, 2020, Novavax announced it had signed a Heads of Terms (Term Sheet) with the Government…
On Jul. 22, 2020, Altimmune announced an agreement with Vigene Biosciences to manufacture AdCOVIDTM, Altimmuneï¾’s single-dose intranasal vaccine…
On Jul. 9, 2020, a study from the NIH showed that neurofilament light chain (NfL) delivered superior diagnostic…
On Jun. 4, 2020, with funding from the Fralin Life Sciences Institute at Virginia Tech, researchers James Weger-Lucarelli…
On Apr. 10, 2020, a new study has begun recruiting at the NIH in Bethesda, Maryland, to determine…
On Apr. 2, 2020, the FDAï¾—in collaboration with the CDC, the Biodefense and Emerging Infections Research Resources Repository…
On Jan. 19, 2017, PharmAthene and Altimmune, a privately-held immunotherapeutics company targeting infectious diseases, announced an agreement for…
On Oct. 1, 2015, The Kavli Foundation announced a $20 million award to establish the Kavli Neural Systems…
On Oct. 1, 2015, The Kavli Foundation announced a $20 million award to establish the Kavli Neuroscience Discovery…
On Aug. 12, 2010, OriGene Technologies based in Rockville, Maryland, announced the acquisition of Blue Heron Biotechnology, a…
On May 20, 2010, researchers at the J. Craig Venter Institute in Maryland published results describing the successful…
In 2010, Hanger announced that it will relocate it’s corporate headquarters was relocated from Bethesda, MD to Austin,…
In 2008, the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center received NCI designation. The mission…
On Jun. 17, 2003, the Advisory Committee on Immunization Practices (ACIP) made recommendations for using intranasally administered, trivalent,…